Press releases
- Press releases
- Browse
Press releases
On January 15th 2003, the European Patent Office has granted final patent protection (EP 1275377A1) to APR's proprietary technology for the preparation of granulates containing liposoluble substances. More
The Population Council, an international public health organisation and FemPharm Pty Ltd., a wholly-owned subsidiary of Acrux Limited, have signed a joint development agreement to test transdermal spray delivery of contraceptive formulations of Nesto More
Acrux Limited announced the commencement of Phase 2 clinical trials of its investigational product for treating women with low libido. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 428 pages - $2,695
Jan 2011 - 124 pages - $1,740
Jun 2009 - 118 pages - $1,040
Nov 2009 - 830 pages - $1,040
Jun 2009 - 110 pages - $1,040
Sep 2009 - 110 pages - $2,995
May 2011 - 112 pages - $3,500
May 2011 - 103 pages - $2,500
May 2011 - 110 pages - $2,500
Your selection
Browse By
- Industry sector
- Intravesical
- Nasal
- Nasal topical
- Ophthalmic
- Oral liquid
- Oral solid
- Otic
- Parenteral
- Pulmonary
- Rectal
- Systemic
- Topical
- Vaginal
- Therapeutic target
- Amenorrahea
- Androgen deficiency
- Endocrine system
- Estrogen replacement
- Growth disorders
- Hormonal disorder (other)
- Hormone replacement therapy
- Hurler's syndrome
- Hypogonadism
- Hypothalamic
- Menopause
- Pancreatic exocrine insufficiency
- Sex hormone (other)
- Testosterone replacement
- Thyroid disorders
- Turner's syndrome
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us